This Article Full Text (OnlineFirst PDF) All Versions of this Article: 1087057109343809v1 14/9/1134    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Scopus Google Scholar Articles by Wetter, J. A. Articles by Hanson, B. J. PubMed PubMed Citation Articles by Wetter, J. A. Articles by Hanson, B. J. Social Bookmarking                         What's this?

Utilization of the Tango^TM -Arrestin Recruitment Technology for Cell-Based EDG Receptor Assay Development and Interrogation

^* To whom correspondence should be addressed. E-mail: justin.wetter{at}invitrogen.com.

	Abstract

Cellular assay development for the endothelial differentiation gene (EDG) family of G-protein-coupled receptors (GPCRs) and related lysophospholipid (LP) receptors is complicated by endogenous receptor expression and divergent receptor signaling. Endogenously expressed LP receptors exist in most tissue culture cell lines. These LP receptors, along with other endogenously expressed GPCRs, contribute to off-target signaling that can complicate interpretation of second-messenger-based cellular assay results. These receptors also activate a diverse and divergent set of cellular signaling pathways, necessitating the use of a variety of assay formats with mismatched procedures and functional readouts. This complicates examination and comparison of these receptors across the entire family. The Tango^TM technology uses the conserved -arrestin-dependent receptor deactivation process to allow interrogation of the EDG and related receptors with a single functional assay. This method also isolates the target receptor signal, allowing the use of tissue culture cell lines regardless of their endogenous receptor expression. The authors describe the use of this technique to build cell-based receptor-specific assays for all 8 members of the EDG receptor family as well as the related LPA receptors GPR23, GPR92, and GPR87. In addition, they demonstrate the value of this technology for identification and investigation of functionally selective receptor compounds as demonstrated by the immunosuppressive compound FTY720-P and its action at the EDG₁ and EDG₃ receptors. (Journal of Biomolecular Screening XXXX:xxx-xxx)

First published on September 2, 2009, doi:10.1177/1087057109343809

Journal of Biomolecular Screening 2009;14:1134.

A more recent version of this article appeared on October 1, 2009


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?